Cinemark Holdings Inc. diskutieren
Cinemark Holdings Inc.
WKN: A0MK44 / Symbol: CNK / Name: Cinemark Hldgs / Aktie / Hotels & Unterhaltung / Mid Cap /
24,46 €
-1,13 %
Cinemark Holdings, Inc. (NYSE: CNK) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $23.00 price target on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $23.00 price target on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $24.00 price target on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $24.00 price target on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) was upgraded by analysts at Roth Mkm from a "neutral" rating to a "buy" rating. They now have a $26.00 price target on the stock, up previously from $19.00.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) was upgraded by analysts at Roth Capital from a "hold" rating to a "strong-buy" rating.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $23.00 price target on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $27.00 price target on the stock, up previously from $16.00.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its price target raised by analysts at Macquarie from $21.00 to $24.00. They now have an "outperform" rating on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its price target raised by analysts at Morgan Stanley from $24.00 to $26.00. They now have an "overweight" rating on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its price target raised by analysts at B. Riley from $27.00 to $31.00. They now have a "buy" rating on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its price target raised by analysts at Roth Mkm from $28.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its price target raised by analysts at Morgan Stanley from $26.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for CNK provided by MarketBeat
Cinemark Holdings, Inc. (NYSE: CNK) had its price target raised by analysts at Wedbush from $28.00 to $31.00. They now have an "outperform" rating on the stock.
Ratings data for CNK provided by MarketBeat
Neueste Beiträge
HC_Wainwright in Arrowhead Pharmaceuticals Inc. diskutieren